Prima BioMed to raise cash for ovarian cancer vaccine trial - FierceVaccines
Links shared publicly online about this topic.
- 264total visits
Prima BioMed to raise cash for ovarian cancer vaccine trial - FierceVaccines
Australia's Prima BioMed plans to raise AU$38 million to fund late-stage trials of CVac, an immunotherapy ovarian cancer vaccine designed to be administered post-surgery and post-chemotherapy to Read more...
View full resource at fiercevaccines.com
Tags: Vaccination, Cancer, Ovarian Cancer, Women's Health, Vaccine, Biomed
Most Recently Shared on May 26, 2011 at 6:23 pm By:
Prima BioMed to raise cash for ovarian cancer vaccine trial. http://bit.ly/jl1fly
PRIMA BIOMED
primabiomed.com.au — “PRIMA BIOMED” View full resource at primabiomed.com.au
Most Recently Shared on May 26, 2011 at 3:30 am By:
Paul Cacciatore Patient Advocate
Prima BioMed hoping 2 raise $38M to fund late-stage trials of its CVac immunotherapy ovarian cancer vaccine. http://dld.bz/abq84
Advertisement
